Dr. Simo Schwartz Jr. has been selected as a member of the European Medicines Agency's Nanomedicine Expert Working Group

The researcher and strategic director of the Biobank and Biomodel at Vall d'Hebron Barcelona Campus Hospital will help create guidelines to regulate the development of new therapies and technologies in this area.


Dr. Simo Schwartz Jr, principal investigator of the Pharmacological Targeting and Release group at Vall d'Hebron Research Institute (VHIR) and strategic director of the Biobank and Biomodel at Vall d'Hebron Barcelona Campus Hospital, has been selected as a member of one of the European Medicines Agency (EMA) Operational Expert Groups. Specifically, the group of experts that assists the Working Group on New Therapies and Technologies in Nanomedicines of the EMA (NTWP Operational Expert Group on nanomedicines).

The objective of this advisory committee is to support the development of guidelines to technically and legally regulate the creation of new therapies and technologies in the area of nanomedicine. The group is currently working on the development of a guideline on the treatment and development of nanomedicines with non-biodegradable parts. Dr. Schwartz Jr. is a leading international scientist in this field with extensive professional experience in the sector. He currently serves as president of the European Association of Nanomedicine.

Share it:

Notícies relacionades


Subscribe to our newsletters and be a part of Campus Life

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.